The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Vulcan Consulting Limited .

Filed returns
10
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2023: 1 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2025: 1 filed returns Sep–Dec 2025: 4 filed returns Jan–Apr 2026: 2 filed returns May–Aug 2026: 1 filed returns 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Vulcan Consulting Limited Health Strategic Operations in Ireland and Healthcare Priorities (Public policy or programme) 13 On lobbying.ie
Jan–Apr 2026 Vulcan Consulting Limited Health Strategic Operations in Ireland and Healthcare Priorities (Public policy or programme) 11 On lobbying.ie
Jan–Apr 2026 Vulcan Consulting Limited Health EU Pharmaceutical Policy (Legislation) 3 On lobbying.ie
Sep–Dec 2025 Vulcan Consulting Limited Health EU Pharmaceutical Policy (Legislation) 3 On lobbying.ie
Sep–Dec 2025 Vulcan Consulting Limited Economic Development and Industry Lilly Operations in Ireland & Europe (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2025 Vulcan Consulting Limited Health Strategic Operations in Ireland & Healthcare Priorities (Public policy or programme) 20 On lobbying.ie
Sep–Dec 2025 Vulcan Consulting Limited Health Diabetes Policy in Ireland (Public policy or programme) 24 On lobbying.ie
Jan–Apr 2025 Vulcan Consulting Limited Health EU Pharmaceutical Policy (Legislation) 4 On lobbying.ie
Sep–Dec 2023 Vulcan Consulting Limited Economic Development and Industry Strategic Operations in Ireland (Matters involving public funds) 4 On lobbying.ie
May–Aug 2023 Vulcan Consulting Limited Health Rare Disease Policy (Public policy or programme) 60 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 8 80.0%
Economic Development and Industry 2 20.0%